Management of locally advanced HPV-related oropharyngeal squamous cell carcinoma: where are we?

Stuart E. Samuels, Avraham Eisbruch, Jonathan J. Beitler, June Corry, Carol R. Bradford, Nabil F. Saba, Michiel W M van Den Brekel, Robert Smee, Primož Strojan, Carlos Suárez, William M. Mendenhall, Robert P. Takes, Juan P. Rodrigo, Missak Haigentz, Alexander D. Rapidis, Alessandra Rinaldo, Alfio Ferlito

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

HPV-related (HPV+) oropharyngeal cancer (OPC) has a better prognosis compared to HPV unrelated (HPV−) OPC. This review summarizes and discusses several of the controversies regarding the management of HPV+ OPC, including the mechanism of its treatment sensitivity, modern surgical techniques, chemotherapy regimens, and treatment de-intensification protocols. We also discuss and reconsider potential adverse prognostic factors such as tumor EGFR expression, tumor hypoxia, and patient smoking history, as well as the significance of retropharyngeal adenopathy. Finally, we discuss elective nodal treatment of uninvolved lymph node stations. While this review does not exhaust all controversies related to the management of HPV+ OPC, it aims to highlight some of the most clinically relevant ones.

Original languageEnglish (US)
JournalEuropean Archives of Oto-Rhino-Laryngology
DOIs
StateAccepted/In press - Oct 13 2015

Fingerprint

Oropharyngeal Neoplasms
Squamous Cell Carcinoma
Therapeutics
Lymph Nodes
Smoking
History
Drug Therapy
Neoplasms

Keywords

  • Cetuximab
  • EGFR
  • HPV
  • Hypoxia
  • Oropharyngeal carcinoma
  • p16
  • Radiosensitivity
  • TORS
  • Treatment de-intensification

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Samuels, S. E., Eisbruch, A., Beitler, J. J., Corry, J., Bradford, C. R., Saba, N. F., ... Ferlito, A. (Accepted/In press). Management of locally advanced HPV-related oropharyngeal squamous cell carcinoma: where are we? European Archives of Oto-Rhino-Laryngology. https://doi.org/10.1007/s00405-015-3771-x

Management of locally advanced HPV-related oropharyngeal squamous cell carcinoma : where are we? / Samuels, Stuart E.; Eisbruch, Avraham; Beitler, Jonathan J.; Corry, June; Bradford, Carol R.; Saba, Nabil F.; van Den Brekel, Michiel W M; Smee, Robert; Strojan, Primož; Suárez, Carlos; Mendenhall, William M.; Takes, Robert P.; Rodrigo, Juan P.; Haigentz, Missak; Rapidis, Alexander D.; Rinaldo, Alessandra; Ferlito, Alfio.

In: European Archives of Oto-Rhino-Laryngology, 13.10.2015.

Research output: Contribution to journalArticle

Samuels, SE, Eisbruch, A, Beitler, JJ, Corry, J, Bradford, CR, Saba, NF, van Den Brekel, MWM, Smee, R, Strojan, P, Suárez, C, Mendenhall, WM, Takes, RP, Rodrigo, JP, Haigentz, M, Rapidis, AD, Rinaldo, A & Ferlito, A 2015, 'Management of locally advanced HPV-related oropharyngeal squamous cell carcinoma: where are we?', European Archives of Oto-Rhino-Laryngology. https://doi.org/10.1007/s00405-015-3771-x
Samuels, Stuart E. ; Eisbruch, Avraham ; Beitler, Jonathan J. ; Corry, June ; Bradford, Carol R. ; Saba, Nabil F. ; van Den Brekel, Michiel W M ; Smee, Robert ; Strojan, Primož ; Suárez, Carlos ; Mendenhall, William M. ; Takes, Robert P. ; Rodrigo, Juan P. ; Haigentz, Missak ; Rapidis, Alexander D. ; Rinaldo, Alessandra ; Ferlito, Alfio. / Management of locally advanced HPV-related oropharyngeal squamous cell carcinoma : where are we?. In: European Archives of Oto-Rhino-Laryngology. 2015.
@article{e7d1bdad2c354541b10b8e2b010ac208,
title = "Management of locally advanced HPV-related oropharyngeal squamous cell carcinoma: where are we?",
abstract = "HPV-related (HPV+) oropharyngeal cancer (OPC) has a better prognosis compared to HPV unrelated (HPV−) OPC. This review summarizes and discusses several of the controversies regarding the management of HPV+ OPC, including the mechanism of its treatment sensitivity, modern surgical techniques, chemotherapy regimens, and treatment de-intensification protocols. We also discuss and reconsider potential adverse prognostic factors such as tumor EGFR expression, tumor hypoxia, and patient smoking history, as well as the significance of retropharyngeal adenopathy. Finally, we discuss elective nodal treatment of uninvolved lymph node stations. While this review does not exhaust all controversies related to the management of HPV+ OPC, it aims to highlight some of the most clinically relevant ones.",
keywords = "Cetuximab, EGFR, HPV, Hypoxia, Oropharyngeal carcinoma, p16, Radiosensitivity, TORS, Treatment de-intensification",
author = "Samuels, {Stuart E.} and Avraham Eisbruch and Beitler, {Jonathan J.} and June Corry and Bradford, {Carol R.} and Saba, {Nabil F.} and {van Den Brekel}, {Michiel W M} and Robert Smee and Primož Strojan and Carlos Su{\'a}rez and Mendenhall, {William M.} and Takes, {Robert P.} and Rodrigo, {Juan P.} and Missak Haigentz and Rapidis, {Alexander D.} and Alessandra Rinaldo and Alfio Ferlito",
year = "2015",
month = "10",
day = "13",
doi = "10.1007/s00405-015-3771-x",
language = "English (US)",
journal = "Archives of Otolaryngology",
issn = "2168-6181",
publisher = "American Medical Association",

}

TY - JOUR

T1 - Management of locally advanced HPV-related oropharyngeal squamous cell carcinoma

T2 - where are we?

AU - Samuels, Stuart E.

AU - Eisbruch, Avraham

AU - Beitler, Jonathan J.

AU - Corry, June

AU - Bradford, Carol R.

AU - Saba, Nabil F.

AU - van Den Brekel, Michiel W M

AU - Smee, Robert

AU - Strojan, Primož

AU - Suárez, Carlos

AU - Mendenhall, William M.

AU - Takes, Robert P.

AU - Rodrigo, Juan P.

AU - Haigentz, Missak

AU - Rapidis, Alexander D.

AU - Rinaldo, Alessandra

AU - Ferlito, Alfio

PY - 2015/10/13

Y1 - 2015/10/13

N2 - HPV-related (HPV+) oropharyngeal cancer (OPC) has a better prognosis compared to HPV unrelated (HPV−) OPC. This review summarizes and discusses several of the controversies regarding the management of HPV+ OPC, including the mechanism of its treatment sensitivity, modern surgical techniques, chemotherapy regimens, and treatment de-intensification protocols. We also discuss and reconsider potential adverse prognostic factors such as tumor EGFR expression, tumor hypoxia, and patient smoking history, as well as the significance of retropharyngeal adenopathy. Finally, we discuss elective nodal treatment of uninvolved lymph node stations. While this review does not exhaust all controversies related to the management of HPV+ OPC, it aims to highlight some of the most clinically relevant ones.

AB - HPV-related (HPV+) oropharyngeal cancer (OPC) has a better prognosis compared to HPV unrelated (HPV−) OPC. This review summarizes and discusses several of the controversies regarding the management of HPV+ OPC, including the mechanism of its treatment sensitivity, modern surgical techniques, chemotherapy regimens, and treatment de-intensification protocols. We also discuss and reconsider potential adverse prognostic factors such as tumor EGFR expression, tumor hypoxia, and patient smoking history, as well as the significance of retropharyngeal adenopathy. Finally, we discuss elective nodal treatment of uninvolved lymph node stations. While this review does not exhaust all controversies related to the management of HPV+ OPC, it aims to highlight some of the most clinically relevant ones.

KW - Cetuximab

KW - EGFR

KW - HPV

KW - Hypoxia

KW - Oropharyngeal carcinoma

KW - p16

KW - Radiosensitivity

KW - TORS

KW - Treatment de-intensification

UR - http://www.scopus.com/inward/record.url?scp=84944556321&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944556321&partnerID=8YFLogxK

U2 - 10.1007/s00405-015-3771-x

DO - 10.1007/s00405-015-3771-x

M3 - Article

C2 - 26463714

AN - SCOPUS:84944556321

JO - Archives of Otolaryngology

JF - Archives of Otolaryngology

SN - 2168-6181

ER -